🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 23 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/10/1989 | 12,17 | 12,42 | 12,15 | 12,31 | +1,81% | 2,29% | 6.438.283 |
| 18/10/1989 | 11,97 | 12,19 | 11,77 | 12,09 | +1,00% | 3,49% | 5.227.843 |
| 17/10/1989 | 11,89 | 12,05 | 11,61 | 11,97 | +0,67% | 3,68% | 7.807.810 |
| 16/10/1989 | 11,07 | 11,93 | 10,95 | 11,89 | +2,75% | 8,80% | 14.779.315 |
| 13/10/1989 | 12,17 | 12,25 | 11,17 | 11,57 | -4,75% | 8,82% | 8.019.715 |
| 12/10/1989 | 12,27 | 12,27 | 12,07 | 12,15 | -1,13% | 1,62% | 2.844.691 |
| 11/10/1989 | 12,33 | 12,34 | 12,21 | 12,29 | -0,64% | 1,13% | 2.504.510 |
| 10/10/1989 | 12,40 | 12,40 | 12,29 | 12,36 | -0,32% | 0,96% | 3.369.110 |
| 09/10/1989 | 12,36 | 12,40 | 12,34 | 12,40 | +0,00% | 0,48% | 1.430.520 |
| 06/10/1989 | 12,36 | 12,40 | 12,31 | 12,40 | +0,32% | 0,80% | 3.528.197 |
| 05/10/1989 | 12,25 | 12,38 | 12,21 | 12,36 | +0,97% | 1,46% | 4.092.230 |
| 04/10/1989 | 12,31 | 12,33 | 12,21 | 12,25 | -0,49% | 0,97% | 4.924.762 |
| 03/10/1989 | 12,13 | 12,33 | 12,09 | 12,31 | +2,14% | 1,97% | 6.503.678 |
| 02/10/1989 | 11,97 | 12,07 | 11,91 | 12,05 | +0,00% | 1,33% | 2.649.134 |
| 29/09/1989 | 12,09 | 12,11 | 11,93 | 12,05 | -0,66% | 1,48% | 4.646.832 |
| 28/09/1989 | 11,81 | 12,13 | 11,81 | 12,13 | +3,04% | 2,69% | 7.150.085 |
| 27/09/1989 | 11,31 | 11,77 | 11,29 | 11,77 | +4,04% | 4,22% | 5.658.571 |
| 26/09/1989 | 11,43 | 11,47 | 11,29 | 11,31 | -0,70% | 1,57% | 4.673.870 |
| 25/09/1989 | 11,41 | 11,43 | 11,35 | 11,39 | -0,69% | 0,70% | 3.313.776 |
| 22/09/1989 | 11,49 | 11,51 | 11,41 | 11,47 | +0,17% | 0,87% | 2.539.094 |
| 21/09/1989 | 11,61 | 11,61 | 11,43 | 11,45 | +0,00% | 1,54% | 3.171.667 |
| 20/09/1989 | 11,41 | 11,47 | 11,37 | 11,45 | +0,00% | 0,87% | 2.839.032 |
| 19/09/1989 | 11,39 | 11,45 | 11,37 | 11,45 | +0,70% | 0,70% | 2.905.056 |
| 18/09/1989 | 11,29 | 11,41 | 11,27 | 11,37 | +0,88% | 1,23% | 3.627.547 |
| 15/09/1989 | 11,21 | 11,31 | 11,15 | 11,27 | +0,71% | 1,42% | 9.985.344 |
| 14/09/1989 | 11,29 | 11,31 | 11,11 | 11,19 | -0,71% | 1,76% | 5.823.317 |
| 13/09/1989 | 11,37 | 11,41 | 11,27 | 11,27 | -0,70% | 1,22% | 6.159.725 |
| 12/09/1989 | 11,37 | 11,45 | 11,33 | 11,35 | -0,70% | 1,05% | 3.594.221 |
| 11/09/1989 | 11,33 | 11,43 | 11,25 | 11,43 | +1,41% | 1,58% | 4.079.654 |
| 08/09/1989 | 11,39 | 11,41 | 11,21 | 11,27 | -0,35% | 1,75% | 6.471.610 |